Peer reviewed
A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design
A phase II randomized placebo-controlled study of fisetin to improve physical function in breast cancer survivors: the TROFFi study rationale and trial design
PubMed / NCBIAccessed Aug 2, 2026
Registry record
Source metadata
- Publisher
- PubMed / NCBI
- Source type
- Peer reviewed
- Registry ID
pubmed-fisetin-troffi-2026- PMID
- 41835341
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.